Re: Chemohormonal Therapy in Metastatic Hormone-sensitive Prostate Cancer

被引:0
|
作者
de Reijke, Theo [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1016/j.eururo.2015.10.037
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:178 / 178
页数:1
相关论文
共 50 条
  • [21] Rezvilutamide for metastatic hormone-sensitive prostate cancer
    Ye, Dingwei
    Gu, Weijie
    Li, Junliang
    LANCET ONCOLOGY, 2022, 23 (11): : E491 - E491
  • [22] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [23] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Bernard, Brandon
    Sweeney, Christopher J.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [24] Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches
    Damodaran, Shivashankar
    Lang, Joshua M.
    Jarrard, David F.
    JOURNAL OF UROLOGY, 2019, 201 (05): : 876 - 885
  • [25] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [26] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [27] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
  • [28] Update on Metastatic Hormone-Sensitive Prostate Cancer
    Chi, Kim N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 277 - 280
  • [29] Influence of aggressive-variant prostate cancer (AVPC) features on outcome of metastatic hormone-sensitive prostate cancer (mHSPC) treated by chemohormonal therapy (CHT).
    Koczka, Kim
    Vanhie, James
    Ibrahim, Andrea
    Bukhari, Nedal
    Reaume, M. Neil
    Sehdev, Sandeep R.
    Potvin, Kylea R.
    Sax, Lori
    Ernst, D. Scott
    Vickers, Michael M.
    Canil, Christina M.
    Winquist, Eric
    Ong, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [30] Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?
    Davis, Ian D.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14